NGNE
Neurogene Inc.
$31.53
+$0.74(+2.40%)
55
Overall
--
Value
90
Tech
21
Quality
Market Cap
$463.79M
Volume
308.96K
52W Range
$14.65 - $37.27
Target Price
$78.75
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | -- | $25.0M | -- | -- | -- | -- | -- | $925.0K | -- | ||
| Total Revenue | -- | -- | $25.0M | -- | -- | -- | -- | -- | $925.0K | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | -- | $25.0M | -- | -- | -- | -- | -- | $925.0K | -- | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $37.6M | $51.1M | $57.6M | $71.0M | $41.6M | $60.7M | $56.5M | $55.6M | $83.5M | $103.3M | ||
| Research & Development | $28.4M | $36.3M | $41.8M | $52.1M | $24.3M | $39.2M | $47.5M | $44.4M | $60.9M | $75.0M | ||
| Research Expense | $28.4M | $36.3M | $41.8M | $4.4M | $24.3M | $39.2M | $47.5M | $44.4M | $60.9M | $75.0M | ||
| Selling, General & Administrative | $9.3M | $14.9M | $15.8M | $18.8M | $17.2M | $21.5M | $9.0M | $11.2M | $22.6M | $28.3M | ||
| General & Administrative Expenses | $9.3M | $14.9M | $15.8M | $18.8M | $17.2M | $21.5M | $9.0M | $11.2M | $22.6M | $28.3M | ||
| Salaries & Wages | $-2.0M | $-3.8M | $-4.7M | $-7.7M | -- | -- | -- | $1.4M | -- | -- | ||
| Depreciation & Amortization | -- | -- | $-300.0K | $-200.0K | $600.0K | $1.1M | $3.2M | $3.3M | $3.2M | -- | ||
| Depreciation & Amortization | -- | -- | $-300.0K | $-200.0K | $600.0K | $1.1M | $3.2M | $3.3M | -- | -- | ||
| Amortization | -- | -- | -- | $-19.0K | $246.0K | $249.0K | $204.0K | $235.0K | $452.0K | -- | ||
| Other Operating Expenses | -- | -- | $41.8M | $-197.0K | $3.1M | $4.8M | $-476.0K | $-574.0K | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-37.6M | $-51.1M | $-32.6M | $-71.0M | $-33.7M | $-60.7M | $-56.5M | $-55.6M | $-82.6M | $-103.3M | ||
| EBITDA | $-37.0M | $-50.2M | $-31.3M | $-68.9M | $-31.4M | $-49.6M | $-52.0M | $-33.0M | $-71.8M | $-87.3M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $1.0K | $4.0K | $4.0K | $1.0K | $14.0K | $-19.0K | $2.0K | $12.0K | $12.0K | $5.0K | ||
| Intinc | -- | -- | -- | $1.5M | -- | -- | $1.3M | $3.0M | $8.5M | $11.5M | ||
| Net Non-Operating Interest Income/Expense | $-1.0K | $-4.0K | $-4.0K | $1.5M | $-14.0K | $19.0K | $-1.3M | $3.0M | $8.5M | $11.5M | ||
| Gain on Sale of Securities | $81.0K | -- | -- | -- | $490.0K | $19.0K | -- | -- | -- | -- | ||
| Other Income/Expense | $-644.0K | $-940.0K | $-1.0M | $14.0K | $-8.3M | $13.0K | $-7.0K | $-16.3M | $994.0K | $-1.4M | ||
| Other Special Charges | $644.0K | $940.0K | $1.0M | $-9.0K | $451.0K | $-13.0K | $-7.0K | $16.3M | $-994.0K | $1.4M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | $1.4M | -- | -- | -- | ||
| Special Income Charges | -- | -- | -- | -- | -- | -- | $-1.4M | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-50.5M | $-55.2M | $-36.3M | $-75.1M | $-90.4M | ||
| Pre-Tax Income | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-60.7M | $-55.2M | $-36.3M | $-75.1M | $-90.4M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-231.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| NET INCOME | ||||||||||||
| Net Income | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-50.5M | $-55.2M | $-36.3M | $-75.1M | $-90.4M | ||
| Net Income (Continuing Operations) | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-60.7M | $-55.2M | $-36.3M | $-75.1M | $-90.4M | ||
| Net Income (Discontinued Operations) | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-50.5M | $-55.2M | $-36.3M | $-75.1M | $-90.4M | ||
| Net Income (Common Stockholders) | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-50.5M | $-55.2M | $-36.3M | $-75.1M | $-90.4M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-89.4M | ||
| TOTALS | ||||||||||||
| Total Expenses | $37.6M | $51.1M | $57.6M | $71.0M | $41.6M | $60.7M | $56.5M | $55.6M | $83.5M | $103.3M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $18.9M | $23.5M | $23.5M | $27.0M | $13.0M | $13.8M | $13.8M | $492.0K | $17.6M | $21.3M | ||
| Average Shares Outstanding (Diluted) | $18.9M | $23.4M | $23.6M | $27.0M | $13.0M | $13.8M | $13.8M | $4.7M | $17.6M | $21.3M | ||
| Shares Outstanding | $23.4M | $23.5M | $23.5M | $38.4M | $10.6M | $10.6M | $10.7M | $12.9M | $14.9M | $15.6M | ||
| Basic EPS | -- | -- | -- | -- | $-2.56 | $-4.4 | $-4.16 | $-73.82 | $-4.28 | $-4.24 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-2.56 | $-4.4 | $-4.16 | -- | $-4.28 | $-4.24 | ||
| Diluted EPS | $-1.96 | $-2.14 | $-1.34 | $-2.57 | $-2.56 | $-4.4 | $-4.16 | $-7.8 | $-4.28 | $-4.24 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-2.57 | -- | $-4.4 | $-4.16 | -- | $-4.28 | $-4.24 | ||
| OTHER METRICS | ||||||||||||
| Development Expense | -- | -- | -- | $47.7M | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | -- | -- | -- | -- | $7.8M | -- | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | $7.8M | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | $-5.0K | $-180.0K | -- | $-118.0K | -- | -- | -- | ||
| Other Gand A | $9.3M | $14.9M | $15.8M | $18.8M | $17.2M | $21.5M | $9.0M | $11.2M | $22.6M | $28.3M | ||
| Rent And Landing Fees | $9.3M | $14.9M | $15.8M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | $1.4M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NGNE | $31.53 | +2.4% | 308.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |